This study addresses the hypothesis that transfection of oligonucleotide mimicking a negative regulatory sequence of promoter C of estrogen receptor alpha (ERa) gene is sufficient for its re-expression in ER-negative human cancer cell lines. Even if the negative transcription regulator subtracted by the transcription factor decoy is not yet been identified, we demonstrated that after this decoy treatment, the cells produced a functional ERa protein able to respond to 17-b-estradiol and to transactivate a transfected estrogen response element (ERE)-regulated reporter gene. The effects of reactivated ERa protein and its estrogen dependence on endogenous target gene expression level, such as ERb, have been also assessed. The proliferation of the cells transfected with low levels of decoy was significantly increased by estrogen and not by tamoxifen, suggesting that the levels of reactivated ERa in these decoy conditions confers a certain hormone sensitivity. On the contrary, high-level expression of ERa obtained at high doses of transfected decoy molecule produced a progressive decrease of cell proliferation. Since ERa is important in the transcription of different genes and its loss is involved in several pathological processes including neoplastic and chronic diseases, our findings may be of relevance for a possible new therapeutical approach of such diseases.
Transcription factor decoy against promoter C of estrogen receptor α gene induces a functional ERα protein in breast cancer cells
LAMBERTINI, Elisabetta;PENOLAZZI, Maria Letizia;MAGALDI, Simona;GIORDANO, Silvia;DEL SENNO, Laura;PIVA, Maria Roberta
2005
Abstract
This study addresses the hypothesis that transfection of oligonucleotide mimicking a negative regulatory sequence of promoter C of estrogen receptor alpha (ERa) gene is sufficient for its re-expression in ER-negative human cancer cell lines. Even if the negative transcription regulator subtracted by the transcription factor decoy is not yet been identified, we demonstrated that after this decoy treatment, the cells produced a functional ERa protein able to respond to 17-b-estradiol and to transactivate a transfected estrogen response element (ERE)-regulated reporter gene. The effects of reactivated ERa protein and its estrogen dependence on endogenous target gene expression level, such as ERb, have been also assessed. The proliferation of the cells transfected with low levels of decoy was significantly increased by estrogen and not by tamoxifen, suggesting that the levels of reactivated ERa in these decoy conditions confers a certain hormone sensitivity. On the contrary, high-level expression of ERa obtained at high doses of transfected decoy molecule produced a progressive decrease of cell proliferation. Since ERa is important in the transcription of different genes and its loss is involved in several pathological processes including neoplastic and chronic diseases, our findings may be of relevance for a possible new therapeutical approach of such diseases.I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.